GANX compared with SVC: revenue, margins and what each company keeps, and the suppliers and customers both name

GANXGain Therapeutics, Inc.

Mkt capRevenueRevenue

SVCService Properties Trust

Mkt capRevenueRevenue

Compare

GANXGain Therapeutics, Inc.

SVCService Properties Trust

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

GANXGain Therapeutics, Inc.

1.16▲+2.34%· post 1.16

Mkt cap$49.3MRevenue—Revenue—

SVCService Properties Trust

6.17▼−1.22%· post 6.17

ClosedNov 3 '26

Mkt cap$809.4MRevenue$325MQ2 FY26Revenue$1.5BFY25

Compare

ClosedNov 3 '26

GANXGain Therapeutics, Inc.

SVCService Properties Trust

1.16▲+2.34%post 1.16

Price

6.17▼−1.22%post 6.17

$49.3M

Mkt cap

$809.4M

—

Revenue

$325MQ2 FY26

—

Revenue

$1.5BFY25

GANX1.16▲+2.34%vsSVC6.17▼−1.22%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GANX: latest quarter not drawable. SVC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GANX 1

—Minoryx Therapeutics, S.Lunlistedsupplier

Shared 0

No shared counterparties.

Only SVC 32

AMCAMC Theatrescustomer

RMRRMRsupplier

—RMR (The RMR Group Inc.)unlistedsupplier

—Sonesta

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

supplier

28 more · SVC chain ›

Price

rebased to 0%

GANX, solidSVC, dashed